Zimmer Announces Name Change and Leadership After Close of Biomet Deal

Officials with Zimmer Holdings Inc. said that once the deal for its neighbor in Warsaw, Ind.—Biomet Inc.—closes, the newly combined firm will be called Zimmer Biomet.

In April, Zimmer executives announced plans to acquire privately held Biomet in a cash-and-stock deal valued at $13.35 billion including Biomet’s debt. Zimmer shareholders will own about 84 percent of the combined company.

Zimmer officials said the combined company will have three divisions: a knee and hip device and bone cement business; a business focused on sports medicine, implants used in the extremities, trauma products, biologic devices, and surgical items; and a business that makes spine, craniomaxillofacial, and dental implants and bone healing products.

Daniel Florin will be its chief financial officer (CFO). Florin has been CFO of Biomet for seven years. Zimmer CFO James Crines will retire following the close of the deal, but will continue to advise the company.

It’s been previously announced that David Dvorak, the president and CEO of Zimmer, will retain his title with the combined company.

“These announcements mark important milestones that will help advance the effective integration of our two companies upon closing,” said Dvorak. “Zimmer and Biomet each have extraordinary talent across all levels, and we are confident that we have put in place a team and organizational structure to drive the combined company into this new chapter. In addition, becoming Zimmer Biomet brings together two well-respected and recognizable names in the industry that share a commitment to new innovations that enhance patient outcomes and improve quality of life.”

Other Zimmer Biomet business units and leadership will include the following:

• Adam R. Johnson, group president, with responsibility for the spine, microfixation, bone healing and dental businesses. Johnson has served in leadership roles at Biomet for 12 years. Johnson currently leads Biomet’s Spine, Microfixation and Bone Healing Division.

• David A. Nolan, group president, with responsibility for the sports medicine, extremities, trauma, biologics and surgical businesses. Nolan has more than 20 years of experience in commercial leadership roles at Biomet and Zimmer. Nolan currently leads Zimmer’s Advanced Solutions portfolio.

• Daniel E. Williamson, group president, with responsibility for the knee, hip and bone cement businesses. Williamson has served in senior leadership roles at Biomet for 24 years. Williamson currently leads Biomet’s Reconstructive Division.

Zimmer Biomet geographic regions and leadership:

• Stuart G. Kleopfer, president, Americas. The Americas region will comprised the United States, Canada and Latin America. Kleopfer has held the U.S. executive leadership position at Biomet for four years and has been with Biomet for 26 years.

• Katarzyna Mazur-Hofsaess, M.D., Ph.D., president, EMEA. The EMEA region will be composed of Europe, the Middle East and Africa. Mazur-Hofsaess has held an EMEA senior leadership position with Zimmer for four years.

• Sang Yi, president, Asia-Pacific. The Asia-Pacific region will comprise China, Japan, India, Australia, New Zealand, Korea and Southeast Asia. Yi has held an Asia-Pacific senior leadership position with Zimmer for two years. Stephen H.L. Ooi, Zimmer’s current president of Asia-Pacific, will retire from his current position at the close of the transaction. Ooi will serve in an advisory role following the close.

Zimmer Biomet functional areas and leadership:

• Robin T. Barney, senior vice president, Global Operations and Logistics. Barney has held the Global Operations and Logistics executive leadership position at Biomet for seven years.

• Audrey M. Beckman, senior vice president, Strategic Quality Initiatives. Beckman has served in senior leadership roles at Zimmer for 18 years and has been with the company for 28 years.
William P. Fisher, senior vice president, Global Human Resources. Fisher has held the Global Human Resources executive leadership position at Zimmer for five years.

• Emmanuel O. Nyakako, senior vice president, Global Quality, Clinical and Regulatory Affairs. Nyakako has held the Global Quality, Clinical and Regulatory Affairs executive leadership position at Zimmer for two years.

• Chad F. Phipps, senior vice president, General Counsel and Secretary. Phipps has held the General Counsel position at Zimmer for seven years.